| Product Code: ETC9404911 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Haemophilia Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Haemophilia Market - Industry Life Cycle |
3.4 South Korea Haemophilia Market - Porter's Five Forces |
3.5 South Korea Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 South Korea Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 South Korea Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 South Korea Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.9 South Korea Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 South Korea Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 South Korea Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about haemophilia and its treatment options |
4.2.2 Growing demand for advanced therapies and treatment modalities |
4.2.3 Supportive government initiatives and policies to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with haemophilia treatment and therapies |
4.3.2 Limited access to specialized healthcare services in certain regions |
4.3.3 Stringent regulatory requirements for approval of new haemophilia treatments |
5 South Korea Haemophilia Market Trends |
6 South Korea Haemophilia Market, By Types |
6.1 South Korea Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 South Korea Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 South Korea Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 South Korea Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.5 South Korea Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F |
6.1.6 South Korea Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F |
6.1.7 South Korea Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F |
6.1.8 South Korea Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.9 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 South Korea Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 South Korea Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 South Korea Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.3 South Korea Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.3.4 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Korea Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 South Korea Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4.3 South Korea Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 South Korea Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 South Korea Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F |
6.5.3 South Korea Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F |
6.5.4 South Korea Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F |
6.5.5 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.6 South Korea Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 South Korea Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 South Korea Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 South Korea Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7 South Korea Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 South Korea Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 South Korea Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 South Korea Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Haemophilia Market Import-Export Trade Statistics |
7.1 South Korea Haemophilia Market Export to Major Countries |
7.2 South Korea Haemophilia Market Imports from Major Countries |
8 South Korea Haemophilia Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation |
8.2 Patient adherence to prescribed treatment regimens |
8.3 Number of healthcare facilities offering comprehensive haemophilia care |
8.4 Rate of adoption of innovative haemophilia treatment options |
8.5 Number of research studies and clinical trials conducted in the field of haemophilia |
9 South Korea Haemophilia Market - Opportunity Assessment |
9.1 South Korea Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 South Korea Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 South Korea Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 South Korea Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.5 South Korea Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 South Korea Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 South Korea Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Haemophilia Market - Competitive Landscape |
10.1 South Korea Haemophilia Market Revenue Share, By Companies, 2024 |
10.2 South Korea Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here